282 related articles for article (PubMed ID: 33173012)
1. Relation between opioid consumption and inclusion of opioids in 137 national essential medicines lists.
Richards GC; Aronson JK; Heneghan C; Mahtani KR; Koshiaris C; Persaud N
BMJ Glob Health; 2020 Nov; 5(11):. PubMed ID: 33173012
[TBL] [Abstract][Full Text] [Related]
2. Comparison of essential medicines lists in 137 countries.
Persaud N; Jiang M; Shaikh R; Bali A; Oronsaye E; Woods H; Drozdzal G; Rajakulasingam Y; Maraj D; Wadhawan S; Umali N; Wang R; McCall M; Aronson JK; Plüddemann A; Moja L; Magrini N; Heneghan C
Bull World Health Organ; 2019 Jun; 97(6):394-404C. PubMed ID: 31210677
[TBL] [Abstract][Full Text] [Related]
3. Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists.
Jarvis JD; Woods H; Bali A; Oronsaye E; Persaud N
PLoS One; 2019; 14(8):e0220781. PubMed ID: 31398195
[TBL] [Abstract][Full Text] [Related]
4. Insights from the WHO and National Lists of Essential Medicines: Focus on Pediatric Diabetes Care in Africa.
Rowlands A; Ameyaw E; Rutagarama F; Dipesalema J; Majaliwa ES; Mbogo J; Ogle GD; Chanoine JP
Horm Res Paediatr; 2018; 90(2):82-92. PubMed ID: 30048982
[TBL] [Abstract][Full Text] [Related]
5. Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO.
Piggott T; Nowak A; Brignardello-Petersen R; Cooke GS; Huttner B; Schünemann HJ; Persaud N; Magrini N; Moja L
BMJ Open; 2022 Feb; 12(2):e053349. PubMed ID: 35144950
[TBL] [Abstract][Full Text] [Related]
6. Biologic medicine inclusion in 138 national essential medicines lists.
Kraus R; Yeung RSM; Persaud N
Pediatr Rheumatol Online J; 2021 Sep; 19(1):140. PubMed ID: 34488779
[TBL] [Abstract][Full Text] [Related]
7. Quantitative evaluation of essential medicines lists: the South African case study.
Perumal-Pillay VA; Suleman F
BMC Health Serv Res; 2016 Dec; 16(1):687. PubMed ID: 27955710
[TBL] [Abstract][Full Text] [Related]
8. Assessing variation among the national essential medicines lists of 21 high-income countries: a cross-sectional study.
Taglione MS; Persaud N
BMJ Open; 2021 Aug; 11(8):e045262. PubMed ID: 34380717
[TBL] [Abstract][Full Text] [Related]
9. Prescription of potentially inappropriate medicines and comparison with lists of essential medicines for treatment of chronic disorders in older patients.
Gu J; Li SJ; Yu A; Xing Z; Kong J; Yang J; Wang YH
Arch Gerontol Geriatr; 2023 Jun; 109():104939. PubMed ID: 36746015
[TBL] [Abstract][Full Text] [Related]
10. Pain Treatment Continues To Be Inaccessible for Many Patients Around the Globe: Second Phase of Opioid Price Watch, a Cross-Sectional Study To Monitor the Prices of Opioids.
Pastrana T; Wenk R; Radbruch L; Ahmed E; De Lima L
J Palliat Med; 2017 Apr; 20(4):378-387. PubMed ID: 27923102
[TBL] [Abstract][Full Text] [Related]
11. Essential medicines for reproductive health: developing evidence based interagency list.
Logez S; Jayasekar S; Moller H; Ahmed K; Patel MU
South Med Rev; 2011 Dec; 4(2):62-8. PubMed ID: 23093884
[TBL] [Abstract][Full Text] [Related]
12. WHO and national lists of essential medicines in Mexico, Central and South America, and the Caribbean: are they adequate to promote paediatric endocrinology and diabetes care?
Rowlands A; Acosta-Gualandri A; Guevara-Aguirre J; Chanoine JP
BMJ Glob Health; 2016; 1(3):e000114. PubMed ID: 28588968
[TBL] [Abstract][Full Text] [Related]
13. Comparison of antibiotics included in national essential medicines lists of 138 countries using the WHO Access, Watch, Reserve (AWaRe) classification: a cross-sectional study.
Adekoya I; Maraj D; Steiner L; Yaphe H; Moja L; Magrini N; Cooke G; Loeb M; Persaud N
Lancet Infect Dis; 2021 Oct; 21(10):1429-1440. PubMed ID: 34332706
[TBL] [Abstract][Full Text] [Related]
14. Essential medicines for cancer: WHO recommendations and national priorities.
Robertson J; Barr R; Shulman LN; Forte GB; Magrini N
Bull World Health Organ; 2016 Oct; 94(10):735-742. PubMed ID: 27843163
[TBL] [Abstract][Full Text] [Related]
15. Global, regional, and national consumption of controlled opioids: a cross-sectional study of 214 countries and non-metropolitan territories.
Richards GC; Aronson JK; Mahtani KR; Heneghan C
Br J Pain; 2022 Feb; 16(1):34-40. PubMed ID: 35111312
[TBL] [Abstract][Full Text] [Related]
16. Opioid availability statistics from the International Narcotics Control Board do not reflect the medical use of opioids: comparison with sales data from Scandinavia.
Bäckryd E; Heilig M; Hoffmann M
Scand J Pain; 2021 Oct; 21(4):696-706. PubMed ID: 34315195
[TBL] [Abstract][Full Text] [Related]
17. Decision criteria for selecting essential medicines and their connection to guidelines: an interpretive descriptive qualitative interview study.
Piggott T; Moja L; Akl EA; Lavis JN; Cooke G; Kredo T; Hogerzeil HV; Huttner B; Alonso-Coello P; Schünemann H
J Clin Epidemiol; 2023 Feb; 154():146-155. PubMed ID: 36584732
[TBL] [Abstract][Full Text] [Related]
18. Essential medicines are more available than other medicines around the globe.
Bazargani YT; Ewen M; de Boer A; Leufkens HG; Mantel-Teeuwisse AK
PLoS One; 2014; 9(2):e87576. PubMed ID: 24533058
[TBL] [Abstract][Full Text] [Related]
19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
20. Opioid Medications in Expensive Formulations Are Sold at a Lower Price than Immediate-Release Morphine in Countries throughout the World: Third Phase of Opioid Price Watch Cross-Sectional Study.
De Lima L; Arias Casais N; Wenk R; Radbruch L; Pastrana T
J Palliat Med; 2018 Oct; 21(10):1458-1465. PubMed ID: 29927698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]